Cambridge technology that removes wind farm clutter from Air Traffic Control radar screens could be rolled out by the end of the year after startup Aveillant clinched £6.75 million fresh funding.
The Martlet angel investment vehicle in Cambridge UK is receiving inquiries from cash-hungry business and technology propositions from all around the world and anticipates having invested more than £1 million before the end of its second year of operation.
Cambridge drug discovery company Domainex is raising £1.5 million to accelerate research by Big Pharma players in the epigenetics arena.
In a shaky economic climate, where fund raising has become tight and there are decreasing opportunities to exit the market, venture capital firms have become extremely cautious in choosing their investments.
Robotics technology specialists in Cambridge companies and the university have been handed a golden chance by the UK government to clinch significant funding for research.
Imperial Innovations, which has a burgeoning investment portfolio in the Cambridge technology cluster, has injected £1.5 million into Semetric, the firm behind global music analytics specialist, Musicmetric.
Cambridge based innovation investors Martlet, headed by Peter Cowley, and Qi3 (led by Nathan Hill) were part of a syndicate that invested around £500k in a London engineering business developing diesel electric hybrid powertrain technology.
Science & technology companies that have their research roots in Cambridge University in the UK have now raised more than £1 billion in funding.
Cambridge UK games trailblazer Frontier Developments has raised over £1.5 million in a record-breaking crowdfunding campaign via Kickstarter.
The Centre for Computing History – one of the most exciting technology ventures in Cambridge UK – has received a significant financial donation from Haverhill Research Park.
Japanese VC giant Astellas Venture Management has pitched into a £3.75 million funding round to boost the global growth plans of Cambridge UK biotherapeutics technology business Bicycle Therapeutics.
Isogenica in Cambridge and Birmingham’s Aston University have secured funding from the Technology Strategy Board (TSB) for a £0.5 million project to develop a gene library assembly technology exclusively licensed to Isogenica.
An independent coffee roasting and packaging company is full of beans after securing £1million funding from Clydesdale Bank – enabling it to buy its 40,000 sq ft premises in Peterborough.
Groundbreaking technology company UltraSoC Technologies has received an investment worth £1 million from Octopus Investments to roll out its new debug technology to major semiconductor companies throughout the world.
- Angels back bug buster with £1.25m investment
- New crowdfunding ‘bank’ hits the streets
- Nujira raises $12 million
- Hauser hails new £1m University fund
- Canute turns tide with £13m bank backing
- Cambridge wins £1m new biomed funding
- Transport business expands with Barclays’ help
- Wellcome Trust revamps key research fund
- Imperial pumps £17m into Cell Medica
- Lab21 raises £5m growth funding
- VCs face crisis of trust
- Enval shares £7.2m angel windfall
- Eye disease cash for TAP Biosystems
- F1 boss backs health portal’s £1m Series A
- £2m US funding for Intelligent Fingerprinting
- Ubisense on course to be Cambridge’s next £1bn company
Page 1 of 4